Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
There is nothing worse than negativity, apart from 100% unquestioning positivity....which seems to be what the day trading ladies want by shouting down anyone with a question or an alternative view!!
Better to ask difficult questions and let people make their own mind up....then at the end of the day people will know more about what they are invested in and cannot say "If only I knew!!".
Bucolic is right. Don't get sucked into a discussion. Pointless as it's merely a platform for BE to table more negativity.
Parmx, lots of typos...but easy to understand. I thank you for your effort.
Although as I hinted at before when responding to FrankM, I'm not sure MED3000 is directly comparable to something like Minoxidil. With MED3000 (placebo derived) there doesn't appear to be an active compound. All the other Dermasys 'formulations' relied on an active compound such as GTN. MED3000 is theorized to work in some physiological way (heating & cooling cycle). This may be patentable also but probably in a different way to the previous 'formulations'.
Even if MED3000 doesn't attain a patent there is nothing to prevent it being sold OTC (assuming regulatory approval is granted)...just that Futura's IP is less strong. Patents & regulatory approval are different things.
Sorry. Too many typos
For anyone who is worried about lack of petent or Dermasys formula being copied.
Futura is applying under De Novo Classification. Read this -
These devices do not fit into any particular class, have no equivalent device that is currently marketed, or have not been determined to be substantially equivalent as the result of a 510(k) application.
Once MED3000 is approved, it would be in the market. Any company that applying to FDA and succeeding is unlinkely. Because there is already quivalent device current in the market.
bald_eagle, you don't need to know how to works for patent. You can find the patent her - https://patents.google.com/patent/US7442369B1/en
If you got time, go through this - https://en.wikipedia.org/wiki/Minoxidil .
The mechanism by which minoxidil promotes hair growth is not fully understood. Minoxidil is a potassium channel opener,[18] causing hyperpolarization of cell membranes
It has been around for 60+ years. But no one knows fully how exactly it works. All just theories.
There were plenty of solutions sold OTC in similar situation as MED3000 now.
FrankMu, you could well be right. You obviously have more experience about patents than any of us (albeit more hardware focussed).
I would just say that the description of Dermasys & all previously patented formulations involved in delivering an active compound (or molecule) through the skin barrier. As far as I'm aware with MED3000 they haven't specified an active compound, the mode of action seems to be different. I'm not sure if this will impact on the type of patent they have applied for.....something to bear in mind perhaps.
They have undertaken research on the mode of action btw....so presumably Futura do want to know how MED3000 actually works. But that might not be for the patent application of course but more for the upcoming negotiations with potential partners.
Don't encourage him, The Italian! He's just repeating the same old crap over and over again with one clear intention.
bald eagle i certainly don't have a problem with sensible questions being asked and can recall a number of occasions where i wished id taken more note of them. i expect we can all say that.good luck.
theItalian, clearly you've thought about this and I reckon your open-minded approach is sensible...the fact that you disagree with me is fine. I openly admit that I don't know enough about the patent process...I'm just trying to ask sensible questions. People like you can make up your own mind whether to investigate further.
Your approach is quite refreshing compared to some of the numbskulls on here who dismiss any comment that disagrees with their cosy view of the world. Personally I like to try to keep an open mind (never easy when one has a vested interest in a company).
Personally I'm not too sure whether potential commercial partners will be that interested in whether MED3000 has a patent, possibly they will just care about whether there is a market. But FUM are making claims about the IP of Dermasys & MED3000 and I feel sensible investors should dig a little deeper on some of the claims being made.
Regards
agree with that frankmu.i really don't think the obtaining of a patent is going to be an issue.not underestimating the regulatory approval hurdles still to be crossed but feeling fairly optimistic in that connection also.
In my experience you don't need to know how something works to get a patent, you just need to cover as many bases as you can. Intellectual Property Agencies are not scientific board carrying out experiments. I have come across and battled patents written without any implementation behind them (again, my area is hardware), their studies of efficacy beating a placebo would, I assume, help convince the patent examiners there's industrial value worth patenting here. What FUM is probably trying to protect is the molecule and formulations they have developed to avoid somebody else's benefiting from their R+D efforts
bald eagle just my opinion and i have no patent experience whatsoever so its probably worthless,but don't think they need to show how it works to obtain a patent.from what i have read they probably need to show that it does work (which they clearly can) but not the method of efficacy.the patent is for a formulation (a combination of 2 or more distinct substances in a particular way) not for the method of operation.if you didn't know how electricity works i suspect you would stll get a patent for a lawnmower. probably a poor analogy but best i could come up with.the position may be different for the ema/fda approvals but even then I'm not sure they would need to demonstrate the method as per parmzx"s post.also the fact that they are bowling on with the applications doesn't suggest to me that they are going into this with the mind set of "oh god we've no idea how this works but lets just hope no one asks us ". either they can explain it or they are confident that they won't have to in detail ,merely supply with acceptable evidence of the fact that it does work.just my opinion of course.
Parmx, wouldn't they need to know how it works to get a patent? Perhaps FrankMu (who has some experience on applying for patents) can comment here.
Ideally they will find out the mode of action - backed up by scientific evidence from someone like Professor Ralph. Once they know how it 'actually' works they can possible optimise the formulation of MED3000....and it will presumably aide their patent application(s).
@bald_eagle, there are many medicines which are being sold OTC and no one knows how they really work. But what we know is they are safe and they work. And some of them are found accidentally. One best example minoxidil - its market size 1077.81 Million USD By The End Of 2025. Durg which being worked out for heart related issues is working for controlling baldness.
1. Application of gel:
Unique combination of solvents including volatile solvents
2. Seconds later:
Volatile solvents evaporate, leaving the remaining solvent supersaturated. The supersaturation powerfully drives the product through the tissue
3. Minutes later:
The product penetrates the skin rapidly offering rapid penetration or sustained release